Hematopoietic Stem Cell Transplantation for Malignant Diseases
PN Munshi, SD Rowley, R Korngold - Clinical Immunology, 2019 - Elsevier
Hematopoietic stem cell transplantation (HSCT) is an effective treatment for most
hematological malignancies. Autologous HSCT targets malignancies in a dose-responsive …
hematological malignancies. Autologous HSCT targets malignancies in a dose-responsive …
Einsatz von 90Y-Ibritumomab-Tiuxetan bei CD20+ Neoplasien vor autologer und allogener Stammzelltransplantation: retrospektiver Vergleich zur Standardtherapie
FJ Fischer - 2016 - refubium.fu-berlin.de
Einleitung: Bei Patienten mit B-Zell Neoplasien gilt der CD20 Antikörper Rituximab als
Standard der Therapie. Um die Therapieergebnisse zu verbessern, wurden inzwischen …
Standard der Therapie. Um die Therapieergebnisse zu verbessern, wurden inzwischen …
[PDF][PDF] Метафорична профілізація концепту partnerwahl (на матеріалі німецької мови)
У статті схарактеризовано мовні засоби вираження метафоричної профілізації
концепту PARTNERWAHL у німецькій мові, який уподібнюється живій істоті, предметові …
концепту PARTNERWAHL у німецькій мові, який уподібнюється живій істоті, предметові …
Use of transplantation in lymphoma: adults
P Bahrami Dahi, G Soriano Hobbs… - Clinical Guide to …, 2015 - Wiley Online Library
Lymphomas are a heterogeneous group of malignancies affecting the immune system;
classically they are divided into Hodgkin lymphoma, accounting for 10% of all lymphomas …
classically they are divided into Hodgkin lymphoma, accounting for 10% of all lymphomas …
[PDF][PDF] Biology of Blood and Marrow Transplantation
abstract The role of hematopoietic cell transplantation (HCT) in the therapy of Hodgkin
lymphoma (HL) in pediatric and adult patients is reviewed and critically evaluated in this …
lymphoma (HL) in pediatric and adult patients is reviewed and critically evaluated in this …
[PDF][PDF] Outcomes and costs of autologous stem cell mobilization with chemotherapy plus G-CSF versus G-CSF alone
JL Liesveld, J Kanda, B McClune… - Bone Marrow …, 2013 - Citeseer
Chemotherapy plus granulocyte colony stimulating factor (G-CSF)(C+ G) and G-CSF alone
are two of the most common methods of mobilizing CD34+ cells for autologous …
are two of the most common methods of mobilizing CD34+ cells for autologous …
Diagnosis and treatment of follicular lymphoma: where do we stand?
EN Libby - International Journal of Hematologic Oncology, 2012 - Taylor & Francis
The treatment of follicular lymphoma (FL) has advanced in the past decade. The routine use
of monoclonal antibodies, arrival of bendamustine and application of radioimmunotherapy …
of monoclonal antibodies, arrival of bendamustine and application of radioimmunotherapy …
[HTML][HTML] Update on the role of autologous hematopoietic stem cell transplantation in follicular lymphoma
M Cabrero, A Redondo, A Martin… - … Journal of Hematology …, 2012 - ncbi.nlm.nih.gov
Follicular lymphoma (FL) remains incurable despite advances in new strategies of treatment,
including monoclonal antibodies (MoAb). Except for early stages, FL is characterized by …
including monoclonal antibodies (MoAb). Except for early stages, FL is characterized by …
Investigating the role of tumour-associated macrophages in a mouse model of B-cell Non-Hodgkin Lymphoma
SL Hallam - 2012 - qmro.qmul.ac.uk
A large number of infiltrating tumour-associated macrophages (TAM) is associated with a
poor prognosis in many diverse cancers. In B-cell Non-Hodgkin Lymphomas (B-NHL), the …
poor prognosis in many diverse cancers. In B-cell Non-Hodgkin Lymphomas (B-NHL), the …